Updated Jul 16, 2026 · Last SEC filing 2026-06-18
OCULAR THERAPEUTIX, INC (OCUL) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-18. 3 Form 8-K material event filings were reported by OCUL in the last 90 days. 5 Form 144 notices of proposed sale were filed for OCUL stock. InsiderAlpha tracks every OCUL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001393434 |
| Form 4 filings (90d) | 13 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 5 |
| Latest Form 4 filing | 2026-06-18 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dugel Pravin | See Remarks | G — Bona-fide gift | 50.1K | $0.00 | — | SEC | |
| Dugel Pravin | See Remarks | G — Bona-fide gift | 50.1K | $0.00 | — | SEC | |
| Warden Charles M | Director | A — Grant or award | 14.0K | $0.00 | — | SEC | |
| Williams Leslie J. | Director | A — Grant or award | 14.0K | $0.00 | — | SEC | |
| LINDSTROM RICHARD L MD | Director | A — Grant or award | 14.0K | $0.00 | — | SEC | |
| RAINES MERILEE | Director | A — Grant or award | 14.0K | $0.00 | — | SEC | |
| Graves Adrienne L | Director | A — Grant or award | 14.0K | $0.00 | — | SEC | |
| Hong Seung Suh | Director | A — Grant or award | 14.0K | $0.00 | — | SEC | |
| Robins Jason Shand | Chief Financial Officer | A — Grant or award | 15.4K | $0.00 | — | SEC | |
| Waheed Nadia | Chief Medical Officer | S — Open-market sale | 14.8K | $8.27 | $123K | SEC | |
| Dugel Pravin | See Remarks | G — Bona-fide gift | 394.7K | $0.00 | — | SEC | |
| Dugel Pravin | See Remarks | G — Bona-fide gift | 394.7K | $0.00 | — | SEC | |
| Heier Jeffrey S. | Chief Scientific Officer | S — Open-market sale | 3.0K | $8.20 | $25K | SEC | |
| Dugel Pravin | See Remarks | S — Open-market sale | 21.2K | $8.20 | $173K | SEC | |
| Nayak Sanjay | Chief Strategy Officer | S — Open-market sale | 1.9K | $8.20 | $15K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for OCULAR THERAPEUTIX, INC (OCUL). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Dugel Pravin | 5 | $173K |
| RAINES MERILEE | 2 | — |
| LINDSTROM RICHARD L MD | 2 | — |
| Graves Adrienne L | 2 | — |
| Robins Jason Shand | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in OCUL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live OCUL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.